4.5 Review

Covid-19 vaccination in pregnancy

Related references

Note: Only part of the references are listed.
Article Behavioral Sciences

Perceptions and knowledge of COVID-19 vaccine safety and efficacy among vaccinated and non-vaccinated obstetric healthcare workers

Tiffany Wang et al.

Summary: The study investigates the perceptions and knowledge of obstetric healthcare workers (HCWs) regarding the COVID-19 vaccine. The findings show that both vaccinated and non-vaccinated obstetric HCWs had accurate knowledge about the vaccine, but vaccinated HCWs tended to endorse beliefs regarding herd immunity and the safety of the vaccine for pregnant and lactating individuals. Additional education and outreach may be needed to help obstetric individuals make informed decisions about receiving the COVID-19 vaccine.

BEHAVIORAL MEDICINE (2023)

Letter Obstetrics & Gynecology

Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy

Stefan Gloeckner et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August-December 2020

Ashley N. Battarbee et al.

Summary: Most pregnant women are worried about COVID-19 illness, but less than 50% are willing to get vaccinated during pregnancy. Non-Hispanic Black and Hispanic women have lower odds of accepting a vaccine, highlighting the need to prioritize strategies to address perceived barriers among groups at high risk for COVID-19.

AMERICAN JOURNAL OF PERINATOLOGY (2022)

Article Obstetrics & Gynecology

Safety-Related Outcomes of Novel mRNA COVID-19 Vaccines in Pregnancy

Angela Nakahara et al.

Summary: This study describes the safety profile and demographic data of pregnant individuals who received an mRNA COVID-19 vaccine. The results show that the frequency of side effects following vaccination was similar between pregnant and nonpregnant individuals, and no serious complications occurred in either group.

AMERICAN JOURNAL OF PERINATOLOGY (2022)

Article Obstetrics & Gynecology

Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: A cross-sectional study

Miranda K. Kiefer et al.

Summary: This study assessed the frequency and characteristics of COVID-19 vaccine hesitancy among pregnant and postpartum individuals. The results showed that individuals with certain sociodemographic characteristics were more likely to express vaccine hesitancy, while those who had family or friends vaccinated for COVID-19, planned vaccination for other vaccines, and perceived vaccination to benefit the baby were less likely to express COVID-19 vaccine hesitancy.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Immunology

The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels

Amihai Rottenstreich et al.

Summary: Maternal antibody levels and transplacental antibody transfer vary based on the gestational age at the time of SARS-CoV-2 vaccination, with lowest levels observed in those vaccinated in the first trimester. A third booster dose may enhance antibody levels and could be beneficial for those who completed the 2-dose vaccine series early in pregnancy.

CLINICAL INFECTIOUS DISEASES (2022)

Article Obstetrics & Gynecology

The association of maternal SARS-CoV-2 vaccination-to-delivery interval and the levels of maternal and cord blood antibodies

Tali Ben-Mayor Bashi et al.

Summary: This study found a positive correlation between maternal and cord blood antibodies levels after receiving the COVID-19 vaccine, especially when tested after 13 days following administration of the first dose of the vaccine.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

Letter Medicine, General & Internal

Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection

Lydia L. Shook et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Public, Environmental & Occupational Health

The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan

Yoshihiko Hosokawa et al.

Summary: Vaccine hesitancy among pregnant women in Japan is high, with concerns about adverse reactions and negative effects on the fetus and breastfeeding being the main reasons. Lack of trust in the government is significantly associated with vaccine hesitancy, while other factors such as age and educational attainment did not show significant correlations. Accurate information dissemination and boosting trust in the government may be key to addressing vaccine hesitancy among pregnant women in Japan.

JOURNAL OF EPIDEMIOLOGY (2022)

Article Obstetrics & Gynecology

Healthcare workers' attitudes about vaccination of pregnant women and those wishing to become pregnant

George Daskalakis et al.

Summary: This study evaluated the attitudes of healthcare workers towards COVID-19 vaccination for women who wish to conceive and those who are pregnant. The results showed that there is hesitancy among physicians and patients regarding vaccination during pregnancy, particularly in the first trimester. The study also found that a significant percentage of women decline to receive vaccination.

JOURNAL OF PERINATAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland

Sarah J. Stock et al.

Summary: Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection outcomes are lacking. However, this study reveals low levels of vaccination uptake by pregnant women compared to women in the general population and that not being vaccinated is associated with increased risk of severe complications of COVID-19 in pregnancy, including perinatal mortality.

NATURE MEDICINE (2022)

Article Nursing

A comparison of COVID-19 vaccination status among pregnant Israeli Jewish and Arab women and psychological distress among the Arab women

Orit Taubman-Ben-Ari et al.

Summary: This study describes the differences in COVID-19 vaccine uptake between pregnant Jewish and Arab women and explores the factors contributing to psychological distress among Arab women. The findings indicate that fewer Jewish women had been infected with the virus compared to Arab women, and more Jewish women had received the vaccine. Poorer health, lower economic status, motherhood, non-vaccination, anxiety over economic damage, family member infection, delivery, and raising the baby were associated with higher psychological distress.

NURSING & HEALTH SCIENCES (2022)

Article Obstetrics & Gynecology

Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery

Yawei J. Yang et al.

Summary: Vaccination against COVID-19 during pregnancy resulted in detectable levels of maternal and umbilical cord anti-spike IgG at delivery. A complete vaccination course, prior history of SARS-CoV-2 infection, and a third-trimester booster dose were associated with the highest levels of maternal and umbilical cord antibodies.

OBSTETRICS AND GYNECOLOGY (2022)

Article Multidisciplinary Sciences

Pregnant women's perceptions of the COVID-19 vaccine: A French survey

Charles Egloff et al.

Summary: This study evaluated pregnant women's perceptions and acceptance of COVID-19 vaccination. The results showed that about one-third of pregnant women were willing to receive the vaccine, with the main reason for refusal being concerns about potential side effects on the fetus. Factors influencing acceptance included age, multiparity, discussion with healthcare providers, and acceptance of the influenza vaccine.

PLOS ONE (2022)

Article Immunology

Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine

Ola Ali Saleh et al.

Summary: This study aimed to assess the compliance of pregnant and postpartum women to influenza vaccine uptake during the winter of 2020/2021 in Israel. The results showed that Jewish women had a higher prevalence of influenza vaccine uptake compared to Arab women, while Arab participants had a stronger level of trust in healthcare providers. The findings highlight the importance of better information dissemination and education for the pregnant and postpartum community regarding the influenza vaccine.

VACCINE (2022)

Article Virology

Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester

Ioana Mihaela Citu et al.

Summary: Current research indicates that COVID-19 vaccines are effective in the general population, but there is a lack of evidence regarding their safety and efficacy in pregnant women. An observational study was conducted to evaluate the outcomes of pregnant women receiving the BNT162b2 and Ad26.COV2.S vaccines.

VIRUSES-BASEL (2022)

Article Pediatrics

Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes

Inbal Goldshtein et al.

Summary: This large population-based study found no evident differences between newborns of women who received BNT162b2 mRNA vaccination during pregnancy, vs those of women who were not vaccinated, and contributes to current evidence in establishing the safety of prenatal vaccine exposure to the newborns. Interpretation of study findings is limited by the observational design.

JAMA PEDIATRICS (2022)

Article Pediatrics

Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy

Nir Kugelman et al.

Summary: Vaccination with the BNT162b2 mRNA COVID-19 vaccine during the second trimester of pregnancy was associated with strong maternal and neonatal humoral responses, reflected in IgG antibody levels. This supports the vaccination of pregnant individuals in the second trimester for maternal protection and newborn safety during the pandemic.

JAMA PEDIATRICS (2022)

Article Public, Environmental & Occupational Health

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged

Natasha B. Halasa et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Immunology

Evaluation of Transplacental Antibody Transfer in SARS-CoV-2-Immunized Pregnant Women

Ching-Ju Shen et al.

Summary: This study assessed the neutralizing antibody levels against wildtype and Delta variants in pregnant women after mRNA vaccination. It found that full vaccination is important for higher antibody levels and supports the recommendation of COVID-19 immunization for pregnant women. However, the lower level of vaccine-induced neutralizing antibodies for the Delta variant highlights the need for more effective vaccine strategies.

VACCINES (2022)

Article Immunology

Approach of Pregnant Women from Poland and the Ukraine to COVID-19 Vaccination-The Role of Medical Consultation

Slawomir Januszek et al.

Summary: This study aims to describe the level of vaccination acceptance and factors influencing the decision to vaccinate among pregnant women. The findings indicate that medical information plays a crucial role in increasing vaccination acceptance among pregnant women.

VACCINES (2022)

Article Immunology

Tolerability of the BNT162b2 COVID-19 Vaccine during Pregnancy among Polish Healthcare Professionals

Wojciech Zdanowski et al.

Summary: This study aimed to determine the tolerability of the BNT162b2 mRNA vaccine in pregnancy in a Polish population. Pregnant women who received the COVID-19 vaccine had less adverse reactions compared to the control group, especially in terms of fever, gastrointestinal symptoms, local skin reactions, and myalgia.

VACCINES (2022)

Article Immunology

Determinants of COVID-19 Vaccination Hesitancy among Romanian Pregnant Women

Ioana Mihaela Citu et al.

Summary: The study investigated COVID-19 vaccine hesitancy among pregnant women in Romania, finding that pregnant women were more hesitant to get vaccinated than non-pregnant women, with social media playing a significant role in influencing their decision. Factors such as low income, belief in social media rumors, and disbelief in the existence of SARS-CoV-2 may contribute to vaccine hesitancy among pregnant women.

VACCINES (2022)

Article Obstetrics & Gynecology

Women perception of SARS-CoV-2 vaccination during pregnancy and subsequent maternal anxiety: a prospective observational study

Ilenia Mappa et al.

Summary: The majority of pregnant women in Italy have a positive attitude towards the SARS-CoV-2 vaccine. However, vaccine campaigns seem to increase maternal anxiety levels, with a more pronounced increase among those with a negative attitude toward the vaccine.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Obstetrics & Gynecology

COVID-19 vaccination during pregnancy: coverage and safety

Helena Blakeway et al.

Summary: This study investigates the uptake and safety of COVID-19 vaccination among pregnant women. The results show that the proportion of vaccinated pregnant women is low, and those who received the vaccine experienced similar pregnancy outcomes compared to unvaccinated pregnant women. There is lower uptake among younger women, non-White ethnicity, and lower socioeconomic background. This study contributes to the evidence on the safety of COVID-19 vaccination in pregnancy and emphasizes the importance of improving awareness among pregnant women and healthcare professionals on vaccine safety.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study

M. Rottenstreich et al.

Summary: This study aimed to evaluate the impact of Covid-19 vaccination during the third trimester of pregnancy on maternal and neonatal outcomes. The results showed a vaccination rate of 40.2% in a population covered by a National Health Insurance Plan, which was not associated with adverse maternal outcomes and even decreased the risk for neonatal adverse outcomes.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Medicine, General & Internal

Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes

Deshayne B. Fell et al.

Summary: A population-based cohort study in Ontario, Canada found that COVID-19 vaccination during pregnancy was not significantly associated with an increased risk of adverse peripartum outcomes compared to vaccination after pregnancy or no vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Editorial Material Medicine, General & Internal

COVID-19 mRNA Vaccines During Pregnancy New Evidence to Help Address Vaccine Hesitancy

Elyse O. Kharbanda et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Medicine, General & Internal

Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes

Maria C. Magnus et al.

Summary: This population-based study conducted in Sweden and Norway showed that vaccination against SARS-CoV-2 during pregnancy, compared with no SARS-CoV-2 vaccination during pregnancy, was not significantly associated with an increased risk of adverse pregnancy outcomes. The majority of vaccinations were administered with mRNA vaccines during the second and third trimesters of pregnancy, which should be considered when interpreting the findings.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Review Multidisciplinary Sciences

Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy

Smriti Prasad et al.

Summary: This study evaluated evidence from 23 studies and found that COVID-19 mRNA vaccines are safe and effective during pregnancy. Vaccination reduces the risk of infection and stillbirth. There is no evidence of adverse outcomes associated with vaccination.

NATURE COMMUNICATIONS (2022)

Article Obstetrics & Gynecology

Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study

Aharon Dick et al.

Summary: SARS-CoV-2 vaccine appears to be safe during pregnancy, with no increase in adverse outcomes. However, women vaccinated during the second trimester may have an increased risk of preterm birth.

BMC PREGNANCY AND CHILDBIRTH (2022)

Article Public, Environmental & Occupational Health

Covid-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020

Kristin K. Sznajder et al.

Summary: Understanding factors associated with vaccine acceptance among pregnant women is crucial for improving vaccine uptake. A survey conducted in Central Pennsylvania, United States found that women who received an influenza vaccine within the past year, were employed full-time, or reported feeling overloaded were more willing to receive the COVID-19 vaccine. Vaccination education for pregnant women, especially those who have not received an influenza vaccine recently, is necessary.

PREVENTIVE MEDICINE REPORTS (2022)

Article Public, Environmental & Occupational Health

COVID-19 vaccine acceptance and associated factors among women attending antenatal and postnatal cares in Central Gondar Zone public hospitals, Northwest Ethiopia

Eden Bishaw Taye et al.

Summary: This study aimed to assess COVID-19 vaccine acceptance and its associated factors among pregnant and postnatal mothers. The study found that the willingness to accept the vaccine was low, and urban residence, worry about COVID-19 disease, and attitudes towards the vaccine were significantly associated with vaccine acceptance.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2022)

Article Obstetrics & Gynecology

Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers

Marta J. Perez et al.

Summary: According to the survey results, most healthcare workers expressed a desire to receive the COVID-19 vaccine. While there were higher levels of negative attitudes towards vaccination among individuals attempting pregnancy and those who are pregnant and lactating, as well as those with a lower perceived occupational risk of contracting COVID-19, these negative feelings were not common and the effect sizes were small.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Article Medicine, General & Internal

Maternal Mortality with SARS-COV-2 during its 4th Wave in Pakistan: The Vaccine Paradox and Pregnancy

Javaria Aslam et al.

Summary: The study aimed to examine the maternal death rate among admitted pregnant patients with SARS-COV-2 during its 4th wave in Pakistan. The findings revealed a significant mortality risk among non-vaccinated pregnant patients with COVID-19.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN (2022)

Letter Obstetrics & Gynecology

COVID-19 vaccination patterns and attitudes among American pregnant individuals

Heather G. Huddleston et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Article Obstetrics & Gynecology

Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

Omer Nir et al.

Summary: This study found that SARS-CoV-2 immunoglobulin G can efficiently transfer across the placenta from pregnant women vaccinated with the BNT162b2 mRNA vaccine to their neonates. There was a positive correlation between antibody concentrations in maternal and cord blood, indicating potential neonatal humoral immunity provided by maternal vaccination.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2022)

Article Immunology

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018

Elise Tessier et al.

Summary: This study assessed the impact of offering maternal pertussis vaccine earlier in pregnancy on hospitalized infant pertussis cases. The results showed a significant decline in the number of preterm infants hospitalized with pertussis in England after the policy change, with preterm infants no longer being overrepresented among hospitalized cases.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

COVID-19 Vaccine Acceptance and Its Associated Factors Among Pregnant Women Attending Antenatal Care Clinic in Southwest Ethiopia: Institutional-Based Cross-Sectional Study

Ayenew Mose et al.

Summary: The study found a COVID-19 vaccine acceptance rate of 70.7% among pregnant women attending antenatal care clinics in Southwest Ethiopia, with factors such as maternal age, educational status, knowledge, and practice being associated with acceptance. Health care workers are recommended to provide education to pregnant women to increase their knowledge about the disease and promote the safety and effectiveness of the COVID-19 vaccine before administration.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Obstetrics & Gynecology

Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy

Lior Kashani-Ligumsky et al.

Summary: Newborns born to mothers vaccinated during pregnancy have higher antibody titers, potentially providing longer protection compared to those born to women infected during pregnancy.

JOURNAL OF PERINATOLOGY (2021)

Article Public, Environmental & Occupational Health

COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries

Malia Skjefte et al.

Summary: The study found that COVID-19 vaccine acceptance among pregnant women and mothers of young children varied globally, with higher acceptance rates in India, the Philippines, and Latin American countries, and lower rates in Russia, the United States, and Australia. The main predictors of vaccine acceptance included confidence in vaccine safety and effectiveness, concern about COVID-19, trust in public health agencies, adherence to mask guidelines, and attitudes towards routine vaccines.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

News Item Medicine, General & Internal

No link between COVID-19 vaccines and early pregnancy loss

[Anonymous]

MEDICAL JOURNAL OF AUSTRALIA (2021)

Article Multidisciplinary Sciences

COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia

Zoe Bradfield et al.

Summary: This study investigated the perceptions and intentions regarding COVID-19 vaccination among consumers and providers of maternity care in Australia. Findings showed that doctors were most likely to be vaccinated, while women were least likely. Doctors and midwifery students were more likely to recommend the vaccine to pregnant women compared to midwives.

PLOS ONE (2021)

Article Cell Biology

COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women

Caroline Atyeo et al.

Summary: During pregnancy, significant immunological changes occur to make the mother immunologically tolerant to the fetus and continue to protect the dyad against pathogens during and after birth. Pregnant women may be less responsive to vaccination or exhibit altered immune responses to vaccination, highlighting the importance of following prime-boost timelines to ensure full immunity is attained in this vulnerable population.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Immunology

Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study

Inna Bleicher et al.

Summary: The study found that receiving mRNA vaccine during pregnancy does not increase the risk of pregnancy complications and is effective in preventing COVID-19 infection.

VACCINE (2021)

Article Immunology

Prenatal maternal COVID-19 vaccination and pregnancy outcomes

Tamar Wainstock et al.

Summary: The study found that prenatal administration of the Pfizer-BioNTech COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. Women who received the vaccine during pregnancy were typically older, more likely to conceive following fertility treatments, and received more prenatal care, but there were no significant differences in pregnancy, delivery, or newborn complications compared to unvaccinated women.

VACCINE (2021)

Article Medicine, General & Internal

COVID-19 Vaccine Acceptability Among Women Who are Pregnant or Planning for Pregnancy in Saudi Arabia: A Cross-Sectional Study

Mohammed Samannodi

Summary: This study found that pregnant women and those planning for pregnancy in Saudi Arabia have moderate levels of perception, hesitancy, perceived benefits, and causes of action regarding the COVID-19 vaccine. More public health awareness is needed to increase public trust in the safety of the COVID-19 vaccine.

PATIENT PREFERENCE AND ADHERENCE (2021)

Article Environmental Sciences

COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study

Abanoub Riad et al.

Summary: The study revealed that pregnant and lactating women have a high level of COVID-19 vaccine acceptance, but they tend to prefer delaying their vaccination. Factors such as pregnancy trimester, education level, employment status, and previous live births were found to be significant determinants for COVID-19 vaccine acceptance among this population subset.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Obstetrics & Gynecology

Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study

Kathryn J. Gray et al.

Summary: The study found that pregnant and lactating women had equivalent antibody titers after receiving the coronavirus disease 2019 mRNA vaccine compared to nonpregnant women, and these titers were higher than those induced by natural infection. Vaccine-induced antibodies were present in umbilical cord blood and breastmilk samples, transferring immunity to neonates through placenta and breastmilk.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Editorial Material Obstetrics & Gynecology

Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy

Leena B. Mithal et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Article Medicine, General & Internal

The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis

Shu Qin Wei et al.

Summary: Infection with COVID-19 during pregnancy may lead to an increased risk of preeclampsia, preterm birth, and other adverse pregnancy outcomes. Severe cases of COVID-19 are particularly associated with higher risks of complications such as preeclampsia, preterm birth, gestational diabetes, and low birth weight.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Article Immunology

Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination

Amihai Rottenstreich et al.

Summary: The study showed that both maternal and neonatal protection were provided by antenatal vaccination with the BNT162b2 vaccine. Specific antibodies were detected in both maternal and cord blood, with concentrations correlating to maternal levels and time since vaccination.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Ai-ris Y. Collier et al.

Summary: This study assessed the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, as well as the responses against emerging SARS-CoV-2 variants. The results showed that pregnant, lactating, and nonpregnant women developed antibody and T-cell responses following vaccination, with antibodies transferred to infant cord blood and breast milk. While antibody titers against the B.1.1.7 and B.1.351 variants were reduced, T-cell responses remained against the viral variants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Obstetrics & Gynecology

COVID-19 vaccine hesitancy in perinatal women: a cross sectional survey

Suruchi Mohan et al.

Summary: The survey revealed a 25% vaccine hesitancy rate among perinatal women towards COVID-19 vaccination. The main concerns were infection risks, with vaccine specific safety concerns being the main factor driving hesitancy. Previous vaccine acceptors also showed hesitancy towards COVID-19 vaccination. About one third of the group cited non availability of the vaccine as a concern.

JOURNAL OF PERINATAL MEDICINE (2021)

Article Medicine, General & Internal

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Tom T. Shimabukuro et al.

Summary: Preliminary data indicates that there are no obvious safety signals among pregnant women who received mRNA Covid-19 vaccines, but more data is needed for further confirmation. Adverse reactions such as injection-site pain were reported more frequently in pregnant women, but most pregnancies resulted in live births with some cases of preterm birth and small size for gestational age.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Pediatrics

Maternal COVID-19 vaccine antibody response and passage into cord blood

Kathryn J. Gray

JOURNAL OF PEDIATRICS (2021)

Article Biotechnology & Applied Microbiology

This choice does not just affect me. Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study

Sarah Geoghegan et al.

Summary: A survey conducted in Ireland during the rollout of the Pfizer-BioNTech vaccine showed that about 38% of pregnant women were willing to receive the COVID-19 vaccine, while a similar proportion were not. Safety concerns for their unborn infants were the primary driver of decision making among the participants.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Biotechnology & Applied Microbiology

Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model

Liyuan Tao et al.

Summary: The study found that there is vaccine hesitancy among pregnant women, and acceptance rate is related to factors such as age, region, education level, pregnancy stage, knowledge on COVID-19, perceived susceptibility, perceived barriers, etc. Targeted efforts are needed to increase vaccine acceptance among vulnerable populations during the COVID-19 pandemic.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Pediatrics

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection The INTERCOVID Multinational Cohort Study

Jose Villar et al.

Summary: This study evaluated the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with pregnant individuals without COVID-19, finding that pregnant individuals with COVID-19 were at higher risk for various complications such as preeclampsia, severe infections, and preterm birth. The findings emphasize the importance for pregnant individuals and clinicians to strictly implement recommended COVID-19 preventive measures.

JAMA PEDIATRICS (2021)

Editorial Material Obstetrics & Gynecology

Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms

Renuka Ananth Kalyan Kadali et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Letter Medicine, General & Internal

Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy

Elyse O. Kharbanda et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Nursing

Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women

Emma Anderson et al.

Summary: The study found that the Covid-19 pandemic has increased the importance of routine maternal vaccines for pregnant women, but women still have concerns about the safety of vaccine administration. Most pregnant women are cautious about receiving the new Covid-19 vaccine, perceiving it as riskier than contracting Covid-19 itself.

MIDWIFERY (2021)

Article Biochemistry & Molecular Biology

Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy

Noa Dagan et al.

Summary: The BNT162b2 COVID-19 vaccine showed high effectiveness in pregnant women in an observational cohort study in Israel, similar to the effectiveness seen in the general population.

NATURE MEDICINE (2021)

Letter Medicine, General & Internal

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion

Lauren H. Zauche et al.

Summary: The risk of spontaneous abortion in early pregnancy after receiving mRNA Covid-19 vaccination is consistent with historical data.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Obstetrics & Gynecology

Administration of the Coronavirus Disease 2019 (COVID-19) Vaccine to Hospitalized Postpartum Patients

Marta J. Perez et al.

OBSTETRICS AND GYNECOLOGY (2021)

Article Multidisciplinary Sciences

Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women

Philippe Deruelle et al.

Summary: Results from an anonymous online survey of French prenatal care providers showed that most providers are in favor of vaccinating pregnant women against SARS-CoV-2, but a significant minority express reservations. Midwives are less likely to recommend vaccination compared to general practitioners and obstetricians.

PLOS ONE (2021)

Article Reproductive Biology

Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine

Christopher J. Bowman et al.

Summary: The vaccine BNT162b2 was found to have no adverse effects on reproduction and development in rats, and its safety for both mothers and offspring was confirmed. This data supports further studies on BNT162b2 in women of childbearing potential, pregnant, and lactating women.

REPRODUCTIVE TOXICOLOGY (2021)

Article Reproductive Biology

Developmental and reproductive safety of AZD1222 (ChAdOx1 nCoV-19) in mice

Richard Stebbings et al.

Summary: The non-clinical study on AZD1222 showed no adverse effects on female reproduction, fetal or pup survival, and development. Antibody responses in dams were maintained throughout gestation and postnatal periods, and seroconversion in fetuses and pups indicated the transfer of immunoglobulins through placental and lactational routes. These results, combined with clinical data from non-pregnant individuals, support the inclusion of pregnant and breastfeeding individuals in AZD1222 clinical studies.

REPRODUCTIVE TOXICOLOGY (2021)

Article Acoustics

Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine

S. Bookstein Peretz et al.

Summary: This observational study compared the immunogenicity and reactogenicity of the Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine between pregnant and non-pregnant women. The study found that pregnant women experienced similar rates of adverse effects following vaccination as non-pregnant women, with lower levels of SARS-CoV-2 IgG. The vaccine was effective in generating a humoral immune response in pregnant women, with no safety concerns identified.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2021)

Article Virology

SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland

Sarah Stuckelberger et al.

Summary: After the first wave of the pandemic, a study in Switzerland found that only a small percentage of pregnant and breastfeeding women were willing to receive the SARS-CoV-2 vaccine, with factors such as older age, higher education, prior influenza vaccination, having an obstetrician as the primary healthcare provider, and being in the third trimester of pregnancy associated with higher vaccine acceptance. This emphasizes the importance of identifying and reducing barriers to immunization in this population, particularly among younger individuals and those with lower education levels.

VIRUSES-BASEL (2021)

Article Public, Environmental & Occupational Health

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021

Hilda Razzaghi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Review Medicine, General & Internal

ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy

Gilbert G. G. Donders et al.

Summary: Pregnancy is considered a risk factor for serious complications of COVID-19 infection, even without additional risk factors present. Current data slightly favor mRNA-based vaccines over vector-based vaccines for pregnant and breastfeeding women, until more safety data becomes available. Policy makers and societies are advised to prioritize pregnant women for SARS-CoV-2 vaccination and to recommend mRNA vaccines until further safety information is obtained.

JOURNAL OF CLINICAL MEDICINE (2021)

Letter Medicine, General & Internal

Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout

Alisa Kachikis et al.

Summary: This cohort study compared short-term reactions following COVID-19 vaccination between pregnant and lactating individuals and those who are not pregnant or lactating but planning pregnancy.

JAMA NETWORK OPEN (2021)

Correction Medicine, Research & Experimental

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine (vol 131, e150319, 2021)

Ofer Beharier et al.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women

Adeel A. Butt et al.

Summary: The study found that mRNA vaccines provide a high level of protection against documented SARS-CoV-2 infection during pregnancy. This supports the inclusion of pregnant women in vaccination campaigns.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Letter Obstetrics & Gynecology

High antibody levels in cord blood from pregnant women vaccinated against COVID-19

Megan E. Trostle et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Letter Obstetrics & Gynecology

Acceptance of COVID-19 vaccination in pregnancy: a survey study

Ariel T. Levy et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Letter Obstetrics & Gynecology

COVID-19 vaccination in pregnancy: early experience from a single institution

Megan E. Trostle et al.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Article Medicine, General & Internal

Predictors of pregnant women's intention to vaccinate against coronavirus disease 2019: A facility-based cross-sectional study in southwest Ethiopia

Shewangizaw Hailemariam et al.

Summary: The intention of pregnant women to vaccinate against COVID-19 is low and associated with education level, residence, compliance with preventive measures, and perception of the vaccine. A widespread public health education campaign is necessary before the vaccination program in Ethiopia, with a special focus on individuals with lower education backgrounds and rural residents.

SAGE OPEN MEDICINE (2021)

Article Obstetrics & Gynecology

Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy

Regan N. Theiler et al.

Summary: In this study, pregnant women who received COVID-19 vaccination were less likely to contract COVID-19 compared to those who did not receive the vaccine, and vaccination during pregnancy did not lead to increased risks of pregnancy or delivery complications. Factors such as older age, higher education level, non-smoking status, use of infertility treatment during current pregnancy, and lower gravidity were associated with a higher likelihood of vaccination.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Article Obstetrics & Gynecology

COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women

Desmond Sutton et al.

Summary: This survey study investigated attitudes toward COVID-19 vaccination among pregnant, nonpregnant, and breastfeeding respondents, finding that nonpregnant respondents were most likely to accept the vaccine, while pregnant respondents were the least likely to do so. Working in healthcare was not associated with vaccine acceptance in this cohort.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Article Obstetrics & Gynecology

Pregnant women's perspectives on severe acute respiratory syndrome coronavirus 2 vaccine

Luigi Carbone et al.

Summary: The majority of pregnant women in Italy are hesitant to receive the COVID-19 vaccine during pregnancy, even though they are generally in favor of vaccines. Pregnancy is considered a key factor in the decision to refuse vaccine prophylaxis.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Letter Medicine, General & Internal

Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage

Maria C. Magnus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Pediatrics

Vaccination during pregnancy: current and possible future recommendations

Kirsten Maertens et al.

EUROPEAN JOURNAL OF PEDIATRICS (2020)

Review Immunology

Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators

Marie Albrecht et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

Article Multidisciplinary Sciences

Transplacental transmission of SARS-CoV-2 infection

Alexandre J. Vivanti et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Congenital Zika syndrome: A systematic review

Danielle A. Freitas et al.

PLOS ONE (2020)

Article Obstetrics & Gynecology

Influenza and Pregnancy No Time for Complacency

Sonja A. Rasmussen et al.

OBSTETRICS AND GYNECOLOGY (2019)

Review Obstetrics & Gynecology

Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature

Alexandre Yazigi et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2017)

Article Obstetrics & Gynecology

Vaccinations for Pregnant Women

Geeta K. Swamy et al.

OBSTETRICS AND GYNECOLOGY (2015)

Review Obstetrics & Gynecology

2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature

Laura G. Mosby et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)

Review Obstetrics & Gynecology

Varicella-zoster virus (chickenpox) infection in pregnancy

Ronald F. Lamont et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)